EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Systematic evaluation of high-throughput PBK modelling strategies for the prediction of intravenous and oral pharmacokinetics in humans

René Geci iD, Domenico Gadaleta, Marina García de Lomana, Rita Ortega-Vallbona, Erika Colombo, Eva Serrano-Candelas, Alicia Paini, Lars Kuepfer, Stephan Schaller

Archives of Toxicology · 2024-08 · 98 (8) · 2659-2676

DOI: 10.1007/s00204-024-03764-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Toxicology, online erschienen am 09.05.2024. Verfasst von René Geci und 8 weiteren Autor:innen. Beteiligte Einrichtung: esqLABS GmbH, Saterland, Germany. rene.geci@esqlabs.com. Hauptthemen laut MEDLINE: Models, Biological, Computer Simulation. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: H2020 Societal Challenges, Universitätsklinikum RWTH Aachen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Physiologically based kinetic (PBK) modelling offers a mechanistic basis for predicting the pharmaco-/toxicokinetics of compounds and thereby provides critical information for integrating toxicity and exposure data to replace animal testing with in vitro or in silico methods. However, traditional PBK modelling depends on animal and human data, which limits its usefulness for non-animal methods. To address this limitation, high-throughput PBK modelling aims to rely exclusively on in vitro and in silico data for model generation. Here, we evaluate a variety of in silico tools and different strategies to parameterise PBK models with input values from various sources in a high-throughput manner. We gather 2000 + publicly available human in vivo concentration–time profiles of 200 + compounds (IV and oral administration), as well as in silico, in vitro and in vivo determined compound-specific parameters required for the PBK modelling of these compounds. Then, we systematically evaluate all possible PBK model parametrisation strategies in PK-Sim and quantify their prediction accuracy against the collected in vivo concentration–time profiles. Our results show that even simple, generic high-throughput PBK modelling can provide accurate predictions of the pharmacokinetics of most compounds (87% of Cmax and 84% of AUC within tenfold). Nevertheless, we also observe major differences in prediction accuracies between the different parameterisation strategies, as well as between different compounds. Finally, we outline a strategy for high-throughput PBK modelling that relies exclusively on freely available tools. Our findings contribute to a more robust understanding of the reliability of high-throughput PBK modelling, which is essential to establish the confidence necessary for its utilisation in Next-Generation Risk Assessment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Models, BiologicalComputer SimulationHumansAdministration, OralPharmacokineticsAdministration, IntravenousHigh-Throughput Screening AssaysPharmaceutical PreparationsAnimals

Stichwörter der Autor:innen

High-throughput PBK modellingNew approach methodologies (NAMs)Next-generation risk assessment (NGRA)PharmacokineticsPhysiologically based kinetic (PBK) modelling

Substanzen

Pharmaceutical Preparations

Autor:innen und Institutionen

  • esqLABS GmbH, Saterland, Germany. rene.geci@esqlabs.com.
  • Institute for Systems Medicine with Focus on Organ Interaction, University Hospital RWTH Aachen, Aachen, Germany. rene.geci@esqlabs.com.
  • Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
  • Machine Learning Research, Research and Development, Pharmaceuticals, Bayer AG, Berlin, Germany.
  • ProtoQSAR SL, CEEI (Centro Europeo de Empresas Innovadoras), Valencia, Spain.
  • esqLABS GmbH, Saterland, Germany.

ORCID-Profile: René Geci

Förderung

  • H2020 Societal Challenges
  • Universitätsklinikum RWTH Aachen

Zitieren

APA

Geci, R., Gadaleta, D., de Lomana, M. G., Ortega-Vallbona, R., Colombo, E., Serrano-Candelas, E., Paini, A., Kuepfer, L., & Schaller, S. (2024). Systematic evaluation of high-throughput PBK modelling strategies for the prediction of intravenous and oral pharmacokinetics in humans. Archives of Toxicology, 98(8), 2659-2676. https://doi.org/10.1007/s00204-024-03764-9

Vancouver

Geci R, Gadaleta D, de Lomana MG, Ortega-Vallbona R, Colombo E, Serrano-Candelas E, et al. Systematic evaluation of high-throughput PBK modelling strategies for the prediction of intravenous and oral pharmacokinetics in humans. Archives of Toxicology. 2024;98(8):2659-2676. doi:10.1007/s00204-024-03764-9

BibTeX
@article{Geci2024,
  author = {Geci, René and Gadaleta, Domenico and de Lomana, Marina García and Ortega-Vallbona, Rita and Colombo, Erika and Serrano-Candelas, Eva and Paini, Alicia and Kuepfer, Lars and Schaller, Stephan},
  title = {Systematic evaluation of high-throughput PBK modelling strategies for the prediction of intravenous and oral pharmacokinetics in humans},
  journal = {Archives of Toxicology},
  year = {2024},
  volume = {98},
  number = {8},
  pages = {2659--2676},
  doi = {10.1007/s00204-024-03764-9}
}
Kostenlos starten →